EditorialJ Gastrointest Oncol2024
Mutant KRAS inhibitors enter the scene of precision therapeutics for pancreatic cancer
- Journal
- J Gastrointest Oncol
- Published
- 1 August 2024
- Citations
- 2
- Type
- Editorial
These are bibliographic fields. A study card, with population, design, endpoints and result direction each tied to a quote, is not in the data yet.
Ask this document
Answers come only from this document’s own text, as highlighted quotes. If it doesn’t say, you are told so instead of given a guess. Only its metadata is loaded so far, so most questions will be declined.
Try